The dairy titan Junlebao has recently drawn widespread attention. On August 20, the company submitted an updated IPO prospectus to the Hong Kong Stock Exchange. This marked its second attempt at a Hong Kong listing, following an initial filing in January that lapsed in July after six months of inactivity. The refreshed prospectus included complete financial data for the full year of 2025 and the first half of 2026, showcasing impressive figures: the top market share in low-temperature liquid milk nationwide, revenue surpassing RMB 20 billion, sustained net profit growth, and a solid gross margin alongside healthy operating cash flow.

The narrative presented was compelling, yet an unexpected hitch emerged just as the story began. On August 26, six days after the filing, Hong Kong's Centre for Food Safety (CFS) issued a notice stating that during routine import inspections, four samples of 1-liter cartons of Junlebao pure milk, imported by Junlebao (Hong Kong) International Trading Co., Ltd., all exceeded the colony count standards set by Hong Kong's Milk Regulation. The proximity of this event to the IPO filing has thrust what might have been a minor inspection issue into the intense spotlight of the capital markets. Whether this quality control stumble will impede Junlebao's path to listing cannot be brushed aside with a simple "none reached the market" response. The real answers depend on financial leverage, supply chain management, and the patience of existing shareholders.

A Carton of Milk Blocking the IPO Path

Let's first clarify the sequence of events. The product in question is 1-liter cartons of Junlebao pure milk, an ultra-high-temperature sterilized milk intended for catering use. Produced on the Chinese mainland on May 7, 2026, with a shelf life until December 6, 2026, it was imported by Junlebao's wholly-owned overseas platform, Junlebao (Hong Kong) International Trading Co., Ltd.. The CFS, through its routine food monitoring program, tested samples at the import level and found all four had colony counts reaching or exceeding 10 per milliliter, surpassing the regulation limit for pasteurized milk. Hong Kong authorities subsequently suspended the import permit for this product. Fortunately, all affected batches were sealed at the importer's warehouse and did not enter the market, leaving other products under the same brand unaffected.

The CFS clarified that the elevated colony count indicates substandard hygiene conditions but does not necessarily imply food poisoning risk. The affected items remain in the importer's storage, with no market distribution, as the import permit for that specific product was temporarily revoked. Other products of the same brand sold in the market are not impacted.

Food safety is paramount, and Junlebao responded formally on the evening of August 30. The company issued a statement explaining that it immediately established a special investigation team to conduct a comprehensive review of the production, dispatch, export, and storage processes for the affected batch. They confirmed the product was packaged in Traditional Chinese characters specifically for the Hong Kong market, passed internal quality checks at the factory meeting both mainland and Hong Kong standards, and adhered to all export supervision procedures during transport and customs clearance. A lab test report from the Shijiazhuang Customs Technical Center on retained samples also confirmed the colony count was compliant. Junlebao concluded that the anomaly was due to improper handling during loading and unloading at the Hong Kong warehouse, which caused some product damage, compromising seal integrity and leading to contamination. The company apologized and pledged to strengthen quality control across the entire process.

Drawing on my background as a securities researcher familiar with this industry, this explanation has evidentiary support, but it raises four critical questions that require more complete answers for both consumers and investors. First, do the sampled items correspond directly to the damaged packages, and can the extent of damage and contamination pathway be fully documented? It seems unlikely inspectors would test a visibly compromised product. Second, who executed the loading and unloading, and how is responsibility allocated among the Hong Kong importer, warehouse services, and the brand owner? Third, if damage could occur at the warehouse stage, why didn't the incoming inspection identify it promptly? Fourth, modern dairy operations typically minimize human intervention with automated processes from source to production. If an issue appears at the end of this chain, has there been a thorough review of every critical step from transportation to production and distribution? Food safety is no trivial matter. The capital market evaluates such incidents not only by recalls and penalties but also by whether the company can close the risk with verifiable evidence. For a dairy producer, the cold chain isn't just delivery—it's the product itself. Passing production checks is only the starting point; delivery in perfect condition to the consumer is the full answer.

On platforms like "Black Cat Complaint," complaints about Junlebao products include spoilage, foreign objects in packaging, and confusing shelf-life labeling. In my personal analysis, this Hong Kong inspection finding, emerging at the logistics tail end, partly reflects lax inbound and outbound warehouse management in some channels and a lack of strong, penetrating oversight of underlying storage and distribution systems as the company expands its national network. From a capital market perspective, such an overseas food safety notice—even without market circulation—will almost certainly trigger targeted inquiries from the Hong Kong Stock Exchange into Junlebao's full-chain quality control, potentially lengthening the IPO review timeline. The market won't fully accept a third-party warehouse liability story and will question the company's control capabilities across its cross-border supply chain. This carton of milk might not halt Junlebao's listing, but it may cause the exchange's scrutiny to shine brighter and longer.

Dissecting the Financials: High Debt-to-Asset Ratio

While the food safety issue is a public relations thorn, the more pressing challenge for Junlebao's IPO is its financial leverage. The prospectus data is clear: as of June 30, 2026, Junlebao's debt-to-asset ratio stood at 76.57%, showing a slight improvement from 80.31% at the end of 2025 but still significantly higher than industry leaders like Yili and Mengniu. The root cause is Junlebao's consistent strategy of heavy asset investment in the full industrial chain. To reduce reliance on external milk sources, the company has built 33 modern self-owned pastures and 20 dairy production facilities, with a dairy herd of approximately 198,000 cows, ranking among the top in China's large-scale dairy sector. This model—raising its own cattle, building its own plants, and controlling its own cold chain—provides supply chain certainty and a quality narrative but also requires sustained large capital expenditures. Net cash flows from investing activities were -RMB 3.76 billion, -RMB 2.33 billion, and -RMB 2.14 billion in 2023, 2024, and 2025, respectively.

These heavy outlays have also led to some overcapacity. Utilization rates for liquid milk plants were 55.1%, 58.1%, 56.3%, and 62.3% for the years 2023, 2024, 2025, and the first half of 2026, respectively. For milk powder and other dairy products, standard capacity utilization was 44.1%, 49.2%, 49.6%, and 46.6% over the same periods. In a market dominated by two dairy giants, Junlebao's achievement of nearly RMB 20 billion in revenue owes much to Wei Lihua's "heavy assets for autonomy" strategy. However, the logic of capital markets doesn't always align with industrial expansion. The flip side of heavy assets is high leverage, high interest costs, and intense repayment pressure. As of June 30, 2026, Junlebao's interest-bearing debt exceeded RMB 10 billion. Finance costs were RMB 929 million, RMB 402 million, and RMB 268 million in 2023, 2024, and 2025, respectively, while Yili's finance costs were negative—meaning its interest income exceeded interest expenses.

Junlebao's strategy to address this is to raise funds through a Hong Kong IPO. The prospectus states that proceeds will primarily fund new plant construction, capacity expansion, production line upgrades, brand development, channel building, R&D, and digitalization. A successful listing would notably ease its debt burden and improve the debt-to-asset ratio. On the other hand, its milk powder business declined from RMB 5.43 billion in 2023 to RMB 4.46 billion in 2025, with only RMB 2.02 billion in the first half of 2026. Demographic shifts and intensifying competition in infant formula are eroding what was once a key profit source. That said, in an industry facing near-zero growth, Junlebao's operational performance has merits. Its strongest asset is its position in low-temperature liquid milk, where it held a 15.6% market share in 2025, ranking first nationally, according to Frost & Sullivan. While this segment has successfully become a growth driver, increasing concentration in a few categories means intensified price wars among giants could directly impact performance. In the first half of 2026, revenue reached RMB 10.61 billion, with main business revenue up 10.3% year-on-year; adjusted net profit was RMB 745 million, up 12.7%. The adjusted net profit margin rose from 3.4% in 2023 to 7.0% in the first half of 2026, with net profit doubling in two years. The growth engine is low-temperature liquid milk, which brought in RMB 4.93 billion in the first half, up 25.2%, accounting for 46.5% of total revenue. The "Yue Xian Huo" brand surged 55.4% to RMB 2.04 billion, while "Jian Chun" grew 10.2% to RMB 2.89 billion, together contributing nearly RMB 5 billion in revenue. Additionally, the milk powder segment boasts a gross margin of 57.5%, with infant formula margins exceeding 62% in the first half of 2026, ranking high in the industry. Operational efficiency has also improved, with the sales expense ratio down to 16.2% from 20.5%. In a stagnant industry, Junlebao has carved out a growth curve through fresh milk and yogurt, achievements that are commendable and serve as important positives for the IPO.

Borrowing While Distributing Dividends: Who's Paying the Price?

One of the most contentious financial moves ahead of Junlebao's IPO is the substantial pre-filing dividend distribution. The prospectus shows dividends declared to shareholders of RMB 530 million, RMB 363 million, and RMB 1.8 billion in 2023, 2024, and 2025, totaling nearly RMB 2.7 billion over three years. Notably, a RMB 1 billion special dividend in October 2025 came just three months before the filing. Who benefited most? Based on shareholding, actual controller Wei Lihua and his family could receive over RMB 1.5 billion. Early institutional investors like Sequoia China, Spring Capital, and Ping An Capital are also major beneficiaries. This creates a stark contrast: on one hand, a persistently high debt-to-asset ratio and substantial annual interest expenses; on the other, nearly all three years' profits distributed, with the controller pocketing over RMB 1.5 billion and a pre-listing special dividend. These two facts sit side by side in the same prospectus, inevitably raising the question: is Junlebao's listing aimed at repaying debt, funding growth, or allowing old shareholders to cash out?

Another notable aspect is Junlebao's "heavy marketing, light R&D" profile. R&D expenses were RMB 106 million, RMB 98.7 million, RMB 91.6 million, and RMB 41.6 million in the reporting periods, declining as a percentage of revenue from 0.61% to 0.44%. In contrast, sales expenses have consistently exceeded RMB 3.3 billion annually, representing over 17% of revenue. As competition intensifies in low-temperature milk cultures, formulations, and processing, shrinking R&D investment raises concerns about the company's innovation and product iteration capabilities—a key risk area for market scrutiny.

The Inescapable Historical Legacy

Junlebao's journey also carries the unavoidable memory of Sanlu. In 1995, Wei Lihua founded Junlebao in Shijiazhuang. In 1999, Sanlu Group invested in a 34% stake through a "brand plus cash" arrangement. When the melamine scandal erupted in 2008, Sanlu collapsed. In April 2009, Wei Lihua bought back the equity for RMB 25 million, severing ties. In December 2010, Mengniu acquired 51% of Junlebao for RMB 469.2 million, and for nine years, Junlebao grew as an independent brand under Mengniu's umbrella. In December 2019, Mengniu sold its entire stake for RMB 4.01 billion, exiting completely. Legally, Junlebao's ties to Sanlu are long severed. But the meaning of "Sanlu" in Chinese consumers' minds requires no elaboration. Investors like Mengniu, Sequoia China, and Spring Capital were subsequently brought in, helping Junlebao evolve into a national dairy player. Yet, legal separation doesn't equate to a clean break in consumer perception. Junlebao's origins from the Sanlu system remain a sensitive nerve in its brand reputation. To this day, social media and consumer reviews still link Junlebao to Sanlu. For a brand carrying such historical baggage, the tolerance for quality control errors is far lower than for competitors. For many consumers, a colony count exceedance might be just "news" for other brands, but for Junlebao, it risks being interpreted as a precursor to history repeating itself. This is why the CFS notice triggered far greater public reaction than the incident's objective severity.

The Road Ahead for the Listing

Examining Junlebao's updated prospectus reveals two sides. The pressures are evident: a persistently high debt-to-asset ratio well above Yili and Mengniu, nearly RMB 2.7 billion in pre-filing dividends raising "cash-out" questions, and the shadow of Sanlu inviting harsher scrutiny. But the resilience is also noteworthy: low-temperature liquid milk has become its largest segment with the top national market share, adjusted net profit has doubled in three years, net margins are improving, and "Yue Xian Huo" has established a foothold in Hong Kong supermarkets, giving its internationalization story genuine substance. Even amid the food safety issue, the affected product never reached consumers, with risk effectively contained at the port.

Junlebao's opportunity lies in its systemic leadership in the low-temperature segment, controlled supply chain, and the strategic steadfastness of Wei Lihua's team over two decades in the industry. Going forward, the company must build a healthier debt structure, a more rational dividend policy, and a more robust quality control loop. This path may be slower, but it is likely steadier. The capital market appreciates growth stories but prioritizes certainty. Junlebao must prove not just "we can grow" but "we can grow steadily." For consumers, food safety allows no room for "almost." A single lapse in any step from pasture to table can destroy years of built trust. Junlebao's statement pledging to "comprehensively strengthen full-process quality control" should not be mere crisis management rhetoric but a principle ingrained in the company's core. After all, capital bets can be replayed, but consumer trust is granted only once.